DuPont
DD
131.08
-2.20
-1.65%
DuPont
US · DD
#1011 by market cap
Listed 1970
131.08
-2.20
-1.65%
Live - 5344 symbols - heartbeat 317s ago
· 2026-10-08 07:00
Pre-market
130.93
-0.11%
After-hours
130.95
-0.10%
Overnight
130.91
-0.13%
- Market cap
- 17.70B
- P/E (TTM)i
- 327.70
- P/Bi
- 1.29
- EPSi
- -5.61
- Div yieldi
- 2.31%
- 52W posi
- 61%
Reader sentiment
Are you bullish or bearish on DD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.48, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.93% YoY
Margins
- Gross margin
- 34.50%
- Operating margin
- 12.56%
- Net margin
- -11.37%
Key ratios & quality
- Enterprise valuei
- 20.17B
- Altman Z-Scorei
- 0.48
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.59B | 15.44B | 14.34B | 12.57B | 13.02B | 6.61B | 6.72B | 6.85B |
| Gross profit | 7.29B | 5.41B | 4.83B | 4.60B | 4.62B | 2.17B | 2.22B | 2.36B |
| Selling & admin expenses | 3.03B | 2.06B | 1.70B | 1.60B | 1.47B | 891.00M | 976.00M | 1.02B |
| Research & development | 1.07B | 689.00M | 625.00M | 557.00M | 536.00M | 192.00M | 203.00M | 193.00M |
| Operating profit | 2.15B | 1.96B | 1.81B | 1.87B | 2.02B | 822.00M | 747.00M | 860.00M |
| Pretax profit | 600.00M | -126.00M | -2.25B | 1.44B | 1.45B | -279.00M | 117.00M | 200.00M |
| Tax | 195.00M | -2.00M | 160.00M | 237.00M | 387.00M | -217.00M | 213.00M | 102.00M |
| Net profit | 4.00B | 600.00M | -2.92B | 6.52B | 5.92B | 462.00M | 738.00M | -738.00M |
| Basic EPS | 15 | 2 | -12 | 36 | 35 | 3 | 5 | -6 |
| Diluted EPS | 14.88 | 2.01 | -12.03 | 35.67 | 35.25 | 2.82 | 5.04 | -5.61 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.61B | 1.75B | 3.07B | -1.87B | 1.68B | 1.82B |
| Gross profit | 543.00M | 606.00M | 1.20B | -1.06B | 602.00M | 639.00M |
| Selling & admin expenses | 234.00M | 262.00M | 387.00M | -108.00M | 255.00M | 269.00M |
| Research & development | 50.00M | 53.00M | 140.00M | -211.00M | 47.00M | 42.00M |
| Operating profit | 184.00M | 217.00M | 547.00M | -652.00M | 232.00M | 260.00M |
| Pretax profit | 97.00M | 78.00M | 327.00M | -738.00M | 181.00M | 266.00M |
| Tax | 17.00M | 54.00M | 19.00M | -89.00M | 31.00M | 75.00M |
| Net profit | -581.00M | 70.00M | -107.00M | -120.00M | 164.00M | 147.00M |
| Basic EPS | -4 | 0 | -1 | -1 | 1 | 1 |
| Diluted EPS | -4.23 | 0.42 | -0.87 | -0.90 | 1.17 | 1.05 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 126.66B | 10.00B | 29.01B | 14.30B | 11.27B | 7.51B | 20.78B | 5.58B |
| Cash & ST investments | 8.58B | 1.54B | 2.54B | 1.97B | 4.96B | 2.39B | 1.79B | 715.00M |
| Inventory | 4.11B | 4.32B | 2.39B | 2.09B | 2.33B | 2.15B | 1.13B | 1.17B |
| Total assets | 187.86B | 69.35B | 70.90B | 45.71B | 41.36B | 38.55B | 36.64B | 21.58B |
| Total current liabilities | 73.31B | 8.35B | 12.23B | 4.93B | 3.73B | 3.10B | 5.50B | 2.31B |
| Short-term debt | 15.00M | 3.83B | 1.00M | 150.00M | 300.00M | -- | 1.85B | 60.00M |
| Long-term debt | 12.62B | 13.62B | 15.61B | 10.63B | 7.77B | 7.79B | 5.31B | 3.13B |
| Total liabilities | 91,955,000,000.00 | 27,793,000,000.00 | 31,834,000,000.00 | 18,657,000,000.00 | 14,338,000,000.00 | 13,827,000,000.00 | 12,843,000,000.00 | 7,472,000,000.00 |
| Total equity | 95.90B | 41.56B | 39.07B | 27.05B | 27.02B | 24.73B | 23.79B | 14.10B |
| Retained earnings | 30.26B | -8.40B | -11.59B | -23.19B | -21.07B | -22.87B | -23.08B | -24.28B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.46B | 6.85B | 10.02B | 5.58B | 5.64B | 4.86B |
| Cash & ST investments | 1.76B | 1.84B | 1.96B | 715.00M | 710.00M | 1.74B |
| Inventory | 2.24B | 2.30B | 1.84B | 1.17B | 1.21B | 1.21B |
| Total assets | 35.98B | 36.56B | 38.04B | 21.58B | 21.45B | 21.06B |
| Total current liabilities | 4.63B | 4.85B | 5.01B | 2.31B | 2.10B | 2.00B |
| Short-term debt | 1.85B | 1.85B | 1.85B | 60.00M | 40.00M | -- |
| Long-term debt | 5.33B | 5.33B | 7.05B | 3.13B | 3.13B | 3.13B |
| Total liabilities | 12,713,000,000.00 | 13,043,000,000.00 | 14,703,000,000.00 | 7,472,000,000.00 | 7,211,000,000.00 | 7,180,000,000.00 |
| Total equity | 23.27B | 23.52B | 23.34B | 14.10B | 14.24B | 13.88B |
| Retained earnings | -23.67B | -23.61B | -23.73B | -24.28B | -24.20B | -24.33B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.73B | 1.41B | 4.10B | 2.28B | 1.25B | 845.00M | 765.00M | 560.00M |
| Depreciation & amortization | 5.92B | 3.20B | 3.09B | 1.11B | 1.14B | 580.00M | 635.00M | 647.00M |
| Free cash flow | 760.00M | -1.24B | 2.83B | -853.00M | 587.00M | -1.22B | 160.00M | 172.00M |
| Dividends paid | -3.49B | -1.61B | -882.00M | -630.00M | -652.00M | -651.00M | -635.00M | -597.00M |
| Stock buybacks / issuance | -4.22B | -2.24B | -175.00M | -2.03B | -4.29B | -1.97B | -450.00M | -468.00M |
| Ending cash balance | 14.02B | 1.58B | 8.78B | 2.08B | 3.77B | 2.80B | 1.89B | 760.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 351.00M | -200.00M | 1.11B | -700.00M | 153.00M | 479.00M |
| Depreciation & amortization | 160.00M | 166.00M | 446.00M | -125.00M | 155.00M | 154.00M |
| Free cash flow | 229.00M | -250.00M | 737.00M | -544.00M | 51.00M | 403.00M |
| Dividends paid | -172.00M | -171.00M | -172.00M | -82.00M | -82.00M | -81.00M |
| Stock buybacks / issuance | 4.00M | 0 | 11.00M | -483.00M | 84.00M | -252.00M |
| Ending cash balance | 1.80B | 1.88B | 3.83B | 760.00M | 753.00M | 1.78B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.93 | 0.73 | -7.42 | 19.92 | 22.14 | 1.66 | 2.95 | -4.18 |
| ROA %i | 2.01 | 0.39 | -4.21 | 11.09 | 13.48 | 1.06 | 1.87 | -2.68 |
| ROIC %i | 3.54 | 0.98 | -3.71 | 14.14 | 17.23 | 1.81 | 2.78 | -2.60 |
| 5-year avg ROE %i | 15.12 | 11.97 | 3.15 | 3.80 | 7.86 | 7.41 | 7.85 | 8.50 |
| EBIT margin %i | 8.14 | 0.90 | -10.44 | 16.34 | 14.90 | 7.46 | 12.58 | 7.49 |
| FCF / sales %i | 0.88 | -- | 13.88 | -- | -- | -- | 11.47 | 2.51 |
| Current ratioi | 1.73 | 1.20 | 2.37 | 2.90 | 3.02 | 2.43 | 3.78 | 2.42 |
| Quick ratioi | 0.16 | 0.64 | 0.41 | 0.84 | 2.00 | 1.54 | 0.57 | 1.03 |
| Debt / assetsi | 6.73 | 25.16 | 22.02 | 23.59 | 19.52 | 20.23 | 19.57 | 14.80 |
| LT debt / equityi | 13.39 | 33.22 | 40.54 | 40.22 | 29.26 | 32.13 | 22.80 | 22.52 |
| Interest coveragei | 4.65 | 0.29 | -2.78 | 5.18 | 3.94 | 2.27 | 4.26 | 1.64 |
| Revenue CAGR (3Y) %i | -22.63 | -31.56 | 7.10 | -17.76 | -5.52 | -22.73 | -18.83 | -19.27 |
| Net income CAGR (3Y) %i | -20.61 | -51.32 | -- | 18.92 | 127.56 | -- | -52.27 | -- |
| FCF CAGR (3Y) %i | -41.42 | -- | -- | -- | -- | -- | -- | -33.58 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -0.32 | -0.84 | -3.28 | -4.18 | -0.16 | 0.30 |
| ROA %i | -0.20 | -0.53 | -2.04 | -2.68 | -0.10 | 0.19 |
| ROIC %i | 0.42 | 0.01 | -1.80 | -2.60 | 0.34 | 0.66 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.78 | 6.69 | 11.20 | 7.49 | 8.01 | 10.00 |
| FCF / sales %i | 10.13 | 8.79 | 10.25 | 2.51 | -- | 9.26 |
| Current ratioi | 1.40 | 1.41 | 2.00 | 2.42 | 2.68 | 2.43 |
| Quick ratioi | 0.88 | 0.90 | 0.86 | 1.03 | 1.15 | 1.74 |
| Debt / assetsi | 19.94 | 19.63 | 23.39 | 14.80 | 14.79 | 14.84 |
| LT debt / equityi | 23.32 | 23.09 | 30.79 | 22.52 | 22.31 | 22.70 |
| Interest coveragei | 2.41 | 2.50 | 4.11 | 1.64 | 2.05 | 3.08 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Diversified Industrials is the largest reported line at 52.94% of revenue, across 2 reported segments.
- Healthcare & Water Technologies follows at 47.06%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Diversified Industrials52.94%
Healthcare & Water Technologies47.06%
Quote time 2026-10-08 07:00:15 · For reference only, not investment advice and not tailored to your situation.